z-logo
open-access-imgOpen Access
Low-Cost Drugs Still Relevant in the Present-Day Era
Author(s) -
S. R. Daga
Publication year - 2021
Publication title -
european journal of clinical medicine
Language(s) - English
Resource type - Journals
ISSN - 2736-5476
DOI - 10.24018/clinicmed.2021.2.6.134
Subject(s) - theophylline , poverty , business , medicine , population , drug , intensive care medicine , pharmacology , environmental health , economic growth , economics
Escalating medical costs contribute to poverty in countries with low resources. The drug costs account for 17 percent of medical expenses. Revisiting time-tested, cost-effective drugs can reduce these costs. Some of them find a place in the WHO Model List of Essential Medicines for Children. The list consists of medicines for a basic healthcare system. They are safe and cost-effective. The present paper identifies co-trimoxazole and chloramphenicol as antimicrobials, chloroquine for malaria, adrenaline, theophylline for asthma, and phenobarbital as an anti-epileptic drug that merits consideration for reviving interest in them and reduce drug treatment costs. What is already known about this subject? • The cost of drugs contributes to rising medical costs. • Medical expenses push a large population below the poverty line. What does this study add? • Rediscovering the relevance of old low-cost drugs is essential. • Revisiting the WHO Model List of Essential Medicines for Children may be useful. • Drugs such as chloramphenicol and theophylline are such examples.  

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here